Proteins behaving badly: The role of hIAPP in type 2 diabetes

A review of the protein human Islet Amylogenic PolyPeptide (hIAPP) and its role in type 2 diabetes, and potential as a treatment option

A global issue There are over 400 million people worldwide currently living with diabetes, and 1.5 million of those people will die as a result of the disease. The vast majority of people living with diabetes (over 90%) have type 2 diabetes. Globally, over 800 billion US dollars is spent annually on treating diabetes, mainly on diabetes-related complications. Cases of […]

Read More… from Proteins behaving badly: The role of hIAPP in type 2 diabetes